Trials / Conditions / Spinocerebellar Ataxia Type 10
Spinocerebellar Ataxia Type 10
4 registered clinical trials studyying Spinocerebellar Ataxia Type 10 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Study of CAD-1883 for Spinocerebellar Ataxia NCT04301284 | Cadent Therapeutics | Phase 2 |
| Unknown | Genetic Mechanism of Conserved Ancestral Haplotype in SCA10 NCT04495426 | The Methodist Hospital Research Institute | — |
| Active Not Recruiting | Troriluzole in Adult Participants With Spinocerebellar Ataxia NCT03701399 | Biohaven Pharmaceuticals, Inc. | Phase 3 |
| Recruiting | Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168 | Sanford Health | — |